Prot #IMGN632-0802: A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia

Project: Research project

Status	Active
Effective start/end date	6/4/20 → 6/4/23

Project Details